Ad
related to: precision diagnostics website
Search results
Results From The WOW.Com Content Network
Precision diagnostics is a branch of precision medicine that involves managing a patient's healthcare model and diagnosing specific diseases based on omics data analytics. [1] The U.S. announced federal funding for precision medicine research efforts in 2015 with the Precision Medicine Initiative. A year later, the Human Personal Omics ...
Swiss Precision Diagnostics GmbH is a Swiss medical diagnostic company, that produces Clearblue-branded pregnancy testing equipment. History The ...
Diag-Nose.io, founded in 2020, is a biotechnology company focused on translating the complexities of the unified airway into precision diagnostic and drug discovery solutions. Their precision medicine technology combines advanced proteomics, computational biology, and AI (machine learning) to create a scalable respiratory biology model.
The global organ transplant diagnostics market size was valued at USD 4.95 billion in 2024 and is projected to reach from USD 5.49 billion in 2025 to USD 12.57 billion by 2033, growing at a CAGR of 10.92% during the forecast period (2025-2033).
GE Healthcare Technologies, Inc. [1] (doing business as GE HealthCare) is a health technology company organized in Delaware and headquartered in Chicago, Illinois.The company was founded by General Electric in 1994, and it operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound ...
Diag-Nose.io, founded in 2020, is a biotechnology company focused on translating the complexities of the unified airway into precision diagnostic and drug discovery solutions. Their precision medicine technology combines advanced proteomics, computational biology, and AI (machine learning) to create a scalable respiratory biology model.
Alere Inc. was a global manufacturer of rapid point-of-care diagnostic tests.The company was founded in 1991 and was headquartered in Waltham, Massachusetts. [2] [3] As of January 2017, the company had a market capitalization of $3.47 billion with an enterprise value of $5.9 billion. [1]
Diag-Nose.io, founded in 2020, is a biotechnology company focused on translating the complexities of the unified airway into precision diagnostic and drug discovery solutions. Their precision medicine technology combines advanced proteomics, computational biology, and AI (machine learning) to create a scalable respiratory biology model.